Disposable Blood Bags Market Introduction and Overview
According to SPER Market Research, the Global Disposable Blood Bags Market is estimated to reach USD 0.42 billion by 2033 with a CAGR of 6.7%.
The report includes an in-depth analysis of the Global Disposable Blood Bags Market, including market size and trends, product mix, applications, and supplier analysis. Disposable blood bags are biomedical equipment that are used to collect, store, transport, and transfuse blood and its constituent parts. They are composed of biocompatible PVC that has been combined with the necessary additives to ensure that it does not interfere with blood contents. Because glass bottles must be properly cleaned, washed, and autoclaved, and there is always the possibility of breakage, disposable blood bags are preferred over glass bottles. Disposable blood bags also aid in the separation of blood components, such as plasma, platelets, and cryoprecipitate, which are used to treat a range of blood illnesses.
- January 2021: Haemonetics Corporation has struck an agreement to buy privately held Cardiva Medical Inc. The purchase is likely to help Haemonetics broaden and enhance its hospital offerings by adding disposable blood bags to its wide and developing interventional cardiology range.
- April 2021: Grifols purchased seven US plasma exchange facilities from Kedrion for USD 55.2 million. Grifols expects to have immediate access to the plasma obtained in these facilities, which acquire about 240,000 litres of plasma per year as a result of the transaction.
Market Opportunities and Challenges
The global disposable blood bag business is expected to increase over the estimated period due to the rising prevalence of blood-related disorders and the increasing need for blood collection and transfer bags. Each year, millions of people are affected by blood problems, according to the National Heart, Lung, and Blood Institute in the United States. Red and white blood cells, platelets, bone marrow, vascular endothelium, and plasma proteins are all affected by haemophilia, anaemias, venous thromboembolism, and other bleeding disorders. These illnesses can be passed down via families or acquired. These problems can result in aberrant blood cell activity, which can lead to disease or have a negative impact on everyone's health.
When plastic bags are used unevenly or are contaminated, the risk of transmitting HIV, hepatitis B or C, and sepsis increases. Hepatitis C, for example, is the most prevalent chronic bloodborne disease spread by blood transfusion. These dangers increase in many low-income nations without a comprehensive healthcare infrastructure for blood collection, storage, and delivery. This is projected to slow the growth of the disposable bag market globally during the forecast period.
Market Competitive Landscape
Because of the huge number of participants, the disposable blood bag market is fragmented and competitive. The big firms are currently focusing their efforts on expanding their businesses in order to increase their market position. The major players in the Global Disposable Blood Bags Market include: Fresenius SE & Co. KGaA, Grifols S.A., Haemonetics Corporation, HLL Lifecare Limited, INNVOL Medical India Limited, Maco Pharma, Neo medic International, Poly Medi cure Limited, Span Healthcare Private Limited, Teleflex Incorporated
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Type, By End User, By Distribution Channel.
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | Fresenius SE & Co. KGaA, Grifols S.A., Haemonetics Corporation, HLL Lifecare Limited, INNVOL Medical India Limited, Maco Pharma, Neo medic International, Poly Medi cure Limited, Span Healthcare Private Limited, Teleflex Incorporated.
|
COVID-19 Impact on Global Disposable Blood Bags Market
The COVID-19 outbreak is expected to have a favourable influence on the global disposable blood bag industry. Passive immunotherapy employing whole blood or plasma from recovered patients has emerged as a viable infection approach in the COVID-19 pandemic. Transfusing neutralising antibodies through convalescent blood is a widely used method in hospitals around the world. Thus, the increasing acceptance of immunotherapy using blood and plasma boosts the use of blood bags, which is expected to fuel market expansion.
Key Target Audience
- Hospitals and Healthcare Facilities
- Blood Banks
- Medical Professionals
- Pharmaceutical Companies
- Blood Transfusion Centres
Our in-depth analysis of the Disposable Blood Bags Market includes the following segments:
|
By Type:
|
Double Blood Bags
Quadruple Blood Bags
Single Blood Bags
Triple Blood Bags
|
|
By End User:
|
Blood Banks
Home Healthcare
Hospitals
NGOs
|
|
By Distribution Channel:
|
Private Sales
Tender Sales
|
|
By Region:
|
Asia-Pacific
Europe
Middle East & Africa
North America
Latin America
|
Key Topics Covered in the Report
- Global Disposable Blood Bags Market Size (FY’2023-FY’2033)
- Overview of Global Disposable Blood Bags Market
- Segmentation of Global Disposable Blood Bags Market By Type (Double Blood Bags, Quadruple Blood Bags, Single Blood Bags, Triple Blood Bags)
- Segmentation of Global Disposable Blood Bags Market By End User (Blood Banks, Home Healthcare, Hospitals, NGOs)
- Segmentation of Global Disposable Blood Bags Market By Distribution Channel (Private Sales, Tender Sales)
- Statistical Snap of Global Disposable Blood Bags Market
- Expansion Analysis of Global Disposable Blood Bags Market
- Problems and Obstacles in Global Disposable Blood Bags Market
- Competitive Landscape in the Global Disposable Blood Bags Market
- Impact of COVID-19 and Demonetization on Global Disposable Blood Bags Market
- Details on Current Investment in Global Disposable Blood Bags Market
- Competitive Analysis of Global Disposable Blood Bags Market
- Prominent Players in the Global Disposable Blood Bags Market
- SWOT Analysis of Global Disposable Blood Bags Market
- Global Disposable Blood Bags Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Disposable Blood Bags Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Disposable Blood Bags Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Disposable Blood Bags Market
7. Global Disposable Blood Bags Market, By Type (USD Million)
7.1. Global Disposable Blood Bags Market Value Share and Forecast, By Type, 2023-2033
7.2. Double Blood Bags
7.3. Quadruple Blood Bags
7.4. Single Blood Bags
7.5. Triple Blood Bags
8. Global Disposable Blood Bags Market, By End User (USD Million)
8.1. Global Disposable Blood Bags Market Value Share and Forecast, By End User, 2023-2033
8.2. Blood Banks
8.3. Home Healthcare
8.4. Hospitals
8.5. NGOs
9. Global Disposable Blood Bags Market, By Distribution Channel (USD Million)
9.1. Global Disposable Blood Bags Market Value Share and Forecast, By Distribution Channel, 2023-2033
9.2. Private Sales
9.3. Tender Sales
10. Global Disposable Blood Bags Market Forecast, 2019-2033 (USD Million)
10.1. Global Disposable Blood Bags Market Size and Market Share
11. Global Disposable Blood Bags Market, By Type 2019-2033 (USD Million)
11.1. Global Disposable Blood Bags Market Size and Market Share By Type (2019-2026)
11.2. Global Disposable Blood Bags Market Size and Market Share By Type (2027-2033)
12. Global Disposable Blood Bags Market, By End User, 2019-2033 (USD Million)
12.1. Global Disposable Blood Bags Market Size and Market Share By End User (2019-2026)
12.2. Global Disposable Blood Bags Market Size and Market Share By End User (2027-2033)
13. Global Disposable Blood Bags Market, By Distribution Channel, 2019-2033 (USD Million)
13.1. Global Disposable Blood Bags Market Size and Market Share By Distribution Channel (2019-2026)
13.2. Global Disposable Blood Bags Market Size and Market Share By Distribution Channel (2027-2033)
14. Global Disposable Blood Bags Market, By Region, 2019-2033 (USD Million)
14.1. Global Disposable Blood Bags Market Size and Market Share By Region (2019-2026)
14.2. Global Disposable Blood Bags Market Size and Market Share By Region (2027-2033)
14.3. Asia-Pacific
14.3.1. Australia
14.3.2. China
14.3.3. India
14.3.4. Japan
14.3.5. South Korea
14.3.6. Rest of Asia-Pacific
14.4. Europe
14.4.1. France
14.4.2. Germany
14.4.3. Italy
14.4.4. Spain
14.4.5. United Kingdom
14.4.6. Rest of Europe
14.5. Middle East and Africa
14.5.1. Kingdom of Saudi Arabia
14.5.2. United Arab Emirates
14.5.3. Rest of Middle East & Africa
14.6. North America
14.6.1. Canada
14.6.2. Mexico
14.6.3. United States
14.7. Latin America
14.7.1. Argentina
14.7.2. Brazil
14.7.3. Rest of Latin America
15. Company Profile
15.1. Fresenius SE & Co. KGaA
15.1.1. Company details
15.1.2. Financial outlook
15.1.3. Product summary
15.1.4. Recent developments
15.2. Grifols S.A.
15.2.1. Company details
15.2.2. Financial outlook
15.2.3. Product summary
15.2.4. Recent developments
15.3. Haemonetics Corporation
15.3.1. Company details
15.3.2. Financial outlook
15.3.3. Product summary
15.3.4. Recent developments
15.4. HLL Lifecare Limited
15.4.1. Company details
15.4.2. Financial outlook
15.4.3. Product summary
15.4.4. Recent developments
15.5. INNVOL Medical India Limited
15.5.1. Company details
15.5.2. Financial outlook
15.5.3. Product summary
15.5.4. Recent developments
15.6. Maco Pharma
15.6.1. Company details
15.6.2. Financial outlook
15.6.3. Product summary
15.6.4. Recent developments
15.7. Neo medic International
15.7.1. Company details
15.7.2. Financial outlook
15.7.3. Product summary
15.7.4. Recent developments
15.8. Poly Medi cure Limited
15.8.1. Company details
15.8.2. Financial outlook
15.8.3. Product summary
15.8.4. Recent developments
15.9. Span Healthcare Private Limited
15.9.1. Company details
15.9.2. Financial outlook
15.9.3. Product summary
15.9.4. Recent developments
15.10. Teleflex Incorporated
15.10.1. Company details
15.10.2. Financial outlook
15.10.3. Product summary
15.10.4. Recent developments
15.11. Others
16. List of Abbreviations
17. Reference Links
18. Conclusion
19. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
